Purchases and Sales Made in Q1 2025 in Chemomab Therapeutics Ltd. (CMMB)
This table provides information about the institutional ownership of Chemomab Therapeutics Ltd. (CMMB) during Q1 2025. The information is specifically focused on institutions that hold shares of Chemomab Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2025
Q1 2025
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
22.1KNew |
$24.1K - $53.9K
|
22.1K
$24.8K
|
|
|
May 12, 2025
Q1 2025
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
16.4K+ 113.24% |
$17.8K - $39.9K
|
30.8K
$34.5K
|
|
|
May 15, 2025
Q1 2025
|
Morgan Stanley
New York, NY |
BUY
|
- |
12.8K+ 12.22% |
$13.9K - $31.1K
|
117K
$131K
|
|
|
Apr 07, 2025
Q1 2025
|
Gamma Investing LLC
Foster City, CA |
BUY
|
- |
6.92K+ 135.75% |
$7.54K - $16.9K
|
12K
$13.5K
|
|
|
Apr 22, 2025
Q1 2025
|
Wetzel Investment Advisors, Inc.
Indianapolis, IN |
BUY
|
- |
1K+ 10.0% |
$1.09K - $2.44K
|
11K
$12.3K
|
|
|
May 13, 2025
Q1 2025
|
Ubs Group Ag
|
BUY
|
- |
398+ 82.06% |
$434 - $971
|
883
$989
|
|
|
Apr 08, 2025
Q1 2025
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
41+ 0.17% |
$44.7 - $100
|
23.8K
$26.7K
|
|
|
May 01, 2025
Q1 2025
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
BUY
|
- |
4+ 4.0% |
$4.36 - $9.76
|
104
$116
|
|
|
May 14, 2025
Q1 2025
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Apr 14, 2025
Q1 2025
|
Gamma Investing LLC
Foster City, CA |
SELL
|
- |
-993- 8.26% |
$1.08K - $2.42K
|
11K
$12.4K
|
|
|
May 07, 2025
Q1 2025
|
Xtx Topco LTD
London, X0 |
SELL
|
- |
-11.7K- 46.75% |
$12.7K - $28.4K
|
13.3K
$14.9K
|
|
|
Apr 28, 2025
Q1 2025
|
Yelin Lapidot Holdings Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-166K- 22.29% |
$181K - $405K
|
578K
$648K
|
|
|
May 15, 2025
Q1 2025
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-314K- 25.86% |
$342K - $767K
|
900K
$1.01M
|